Lifevantage (NASDAQ:LFVN) Releases Quarterly Earnings Results

Lifevantage (NASDAQ:LFVN) issued its quarterly earnings results on Thursday. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01), FiscalAI reports. The firm had revenue of $42.38 million during the quarter, compared to the consensus estimate of $44.00 million. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%.

Here are the key takeaways from Lifevantage’s conference call:

• Fourth-quarter revenue fell 23.1% year over year to $42.4 million, driven by fewer orders, lower average order values, weaker MindBody GLP-1 System sales, and macroeconomic pressure. Adjusted EBITDA declined to $2.7 million from $4.8 million.
• Management expects difficult year-over-year comparisons in fiscal 2027’s first and second quarters and is not providing formal guidance amid the recent CEO transition; it hopes new strategies can improve momentum in the second half of the fiscal year.
• New CEO Terrence Moorehead outlined priorities to strengthen the brand, improve consumer relevance and sales-force tools, upgrade digital and e-commerce capabilities, and enhance operational efficiency. Management emphasized LifeVantage’s differentiated science and historically strong gross margins, but acknowledged substantial execution work remains.
• The company ended fiscal 2026 with $14.9 million in cash and no debt, generated $10.2 million in operating cash flow, and retains access to a $5 million revolving credit facility.
• LifeVantage continued returning capital through approximately $2 million of fiscal 2026 share repurchases and initiated a $0.05 quarterly dividend; $58.5 million remains available under its share-repurchase authorization.

Lifevantage Stock Down 2.4%

NASDAQ:LFVN opened at $6.45 on Friday. Lifevantage has a twelve month low of $3.90 and a twelve month high of $14.28. The firm has a market capitalization of $81.40 million, a price-to-earnings ratio of 14.33 and a beta of 0.72. The stock’s 50 day moving average price is $6.42 and its two-hundred day moving average price is $5.84.

Lifevantage Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.20 annualized dividend and a dividend yield of 3.1%. Lifevantage’s payout ratio is 44.44%.

Wall Street Analysts Forecast Growth

LFVN has been the topic of a number of recent research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a report on Friday, August 21st. Lake Street Capital cut shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price for the company. in a report on Thursday, May 7th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Lifevantage presently has an average rating of “Hold” and a consensus target price of $5.00.

Hedge Funds Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC increased its stake in shares of Lifevantage by 8.3% during the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock worth $5,685,000 after purchasing an additional 70,900 shares during the last quarter. Wasatch Advisors LP grew its holdings in Lifevantage by 6.6% during the second quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after purchasing an additional 27,765 shares during the period. Geode Capital Management LLC increased its position in Lifevantage by 106.1% during the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after buying an additional 126,274 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Lifevantage by 305.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock worth $1,233,000 after buying an additional 150,785 shares during the last quarter. Finally, State Street Corp raised its stake in Lifevantage by 8.5% in the fourth quarter. State Street Corp now owns 181,833 shares of the company’s stock valued at $1,120,000 after buying an additional 14,178 shares during the period. 35.32% of the stock is owned by institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.